The Critical Ides of October

  • by: |
  • 10/04/2007
It's time for the best and the brightest to serve their country ...

FDA Seeks Nominations for Reagan-Udall Foundation

The U.S. Food and Drug Administration is seeking nominations from patient and consumer advocacy groups, professional scientific and medical societies, and industry trade organizations to serve on the board of directors of the newly created Reagan-Udall Foundation.

Title VI of the recently enacted Food and Drug Administration Amendments Act of 2007 created the foundation to advance the mission of FDA to modernize medical, veterinary, food, food ingredient, and cosmetic product development, accelerate innovation, and enhance product safety.

The foundation will be a private, independent, nonprofit entity. The statute calls for a diverse 14-member board: four representatives from the general pharmaceutical, device, food, cosmetic and biotechnology industries; three representatives from academic research organizations; two representatives from patient or consumer advocacy groups; one member representing health care providers; and, four at-large representatives with expertise or experience relevant to the purpose of the Reagan-Udall Foundation.

"A concerted effort by government, industry and academia is needed to modernize the scientific tools used to develop products and to monitor their safety once they go to market," said Commissioner of Food and Drugs Andrew C. von Eschenbach. "We are looking forward to foundation candidates who will work with us to embrace the transformational nature of future efforts to protect and promote the public health."

The foundation will identify unmet scientific needs in the development, manufacture, and evaluation of the safety and effectiveness of FDA regulated products, including post-market evaluation, and establish scientific projects and programs to address those needs. It will help accomplish the scientific work the FDA needs to support its regulatory mission. The foundation will be an important vehicle for private and public stakeholders to collaborate to address the priorities and opportunities identified in FDA's Critical Path reports, and to help modernize the product evaluation sciences.

FDA, the National Institutes of Health, Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality have 30 days to appoint the foundation's board of directors. FDA will handle the submission process. Nine members are to be appointed from a list of candidates provided by the National Academy of Sciences. Five members are to be appointed from lists of candidates submitted by organizations mentioned above.

Interested persons may submit nominations by facsimile to Lisa Rovin or Nancy Stanisic at 301-443-9718, or by e-mail to All nominations must be received on or before Oct. 15, 2007.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog